Otsuka Holdings Co., Ltd.
Notice of Full-Year Financial Forecast Revision and Dividend Increase for FY2026
Otsuka Holdings has upwardly revised its full-year consolidated earnings forecast for FY2026, projecting net sales of 2,725 billion yen (8.1% increase from previous forecast) and net income of 355 billion yen (33.8% increase). The interim dividend has been increased from 70 yen to 100 yen, and the annual dividend has been revised to 200 yen.
Key Figures
- Net Sales Revenue: 2,725 billion yen (8.1% increase from previous forecast)
- Net Income Attributable to Owners of Parent: 355 billion yen (33.8% increase)
- Earnings Per Share: 675.47 yen (34.0% increase)
AI要約
Performance Overview
Otsuka Holdings has upwardly revised its full-year consolidated earnings forecast for FY2026, projecting net sales of 2,725 billion yen (8.1% increase from previous forecast) and net income of 355 billion yen (33.8% increase). The outlook has been improved due to solid performance in the healthcare-related and NC-related businesses. Notably, growth in antipsychotic and anticancer drugs has contributed to the favorable outlook for the healthcare segment. Additionally, a weaker yen has supported earnings upside.
Dividend Policy and Future Approach
The interim dividend has been increased from 70 yen to 100 yen, and the annual dividend has been revised to 200 yen. This increase reflects the upward revision of the FY2026 earnings forecast and the improved consolidated earnings outlook. The basic policy remains to increase or maintain dividends annually, aiming to strengthen shareholder returns.
Net Sales Trend
Net Income Attributable to Owners of Parent
Dividend Trend
Forecast vs Actual Comparison
Otsuka Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
